AIDS Drug Rebates Were “Largest Driver” Of ADAP Budget Growth In 2007
Executive Summary
Manufacturer rebates on AIDS drugs now account for 18 percent of the overall budget for AIDS Drug Assistance Programs, compared to 6 percent in the mid-1990s, according to the National ADAP Monitoring Project's annual report, released April 8
You may also be interested in...
Merck’s Isentress – Is $27/Day A High Price To Pay For HIV Treatment?
Merck's first-in-class integrase inhibitor Isentress marks the firm's return to the HIV market, but also to the intense pricing scrutiny that surrounds AIDS products
Pfizer Selzentry Will Launch At $29/Day; sNDA For Full Approval Slated For August
Pfizer's HIV therapy Selzentry (maraviroc) will be available in pharmacies by mid-September following FDA's Aug. 6 approval of the first-in-class CCR5 co-receptor antagonist
Pharma's Reform Bounce: How Big a Bounce Will $80 Bil. Buy?
Drug manufacturers made a pledge to contribute $80 bil. in a mix of savings and revenue-raising initiatives to help fund health reform. In return, they could see a wide range of new business depending on how you look at the numbers.